• Acute Myeloid Leukemia

Dr. Krakow's research focus is on developing safer, more effective cellular immunotherapies to treat patients whose cancer has relapsed after BMT. For example, in one trial she used donor T cells (immune cells) that have been genetically modified with receptors to target leukemia.